This multicenter prospective registry aims to establish a biobank of residual biological samples and associated clinical data from hospitalized patients. The registry will collect a wide range of specimens (serum, plasma, respiratory samples, urine, cerebrospinal fluid, biopsies) obtained during routine care, without any additional procedures. Data are pseudonymized and stored securely for up to 20 years. The biobank will be used to develop and evaluate rapid diagnostic tests (RDTs) for emerging infectious diseases and CBRN threats to improve epidemic preparedness and patient management.
Adults (≥ 18 years old) hospitalized in one of the participating centers at Bicêtre or Paul Brousse hospitals, for whom residual biological samples are available as part of routine care in one or more participating hospital departments.
Covered by, or entitled to, the French social security system (excluding State Medical Aid - AME).
Patient or legal representative/trusted person informed about the registry and having provided written consent to participate.
Patients under judicial protection (guardianship or curatorship).
Patients deprived of liberty by judicial or administrative decision.
Patients not speaking French and not accompanied by a translator.
Patients hospitalized in one of the participating study centers
Cohort
Prospective
Not listed
Number of residual clinical samples successfully collected, aliquoted, and stored with associated clinical and microbiological data
Creation of a collection of residual biological samples (serum, plasma, urine, respiratory samples, CSF, biopsies, etc.) and associated clinical and microbiological data obtained during routine care
Click on the lead sponsor to view all of their trials.
Assistance Publique - Hôpitaux de Paris
Lead sponsor
NG Biotech
Collaborator
Commissariat A L'energie Atomique
Collaborator
